Christophe Weber, CEO Takeda / Getty Images
Takeda turns to emerging markets, Western Europe in scramble to offload Shire debt — report
Weighed down by nearly $50 billion in debt since the Shire deal, Takeda is selling off drugs in emerging markets and Western Europe in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
